Germantown, MD, United States of America

Clayton D Collier

This inventor holds 2 USPTO granted patents. Top assignee: Digene Corporation. Active years: 1999-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Clayton D Collier. Retrieved from https://idiyas.com/inventor/clayton-d-collier

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.4

ph-index = 2

Forward Citations = 81(Granted Patents)


Location History:

  • Silver Spring, MD (US) (1999)
  • Germantown, MD (US) (2001)

Company Filing History:


Years Active: 1999-2001

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Clayton D Collier

Introduction

Clayton D Collier is a notable inventor based in Germantown, MD (US). He has made significant contributions to the field of molecular biology, particularly in the detection of RNA molecules. With a total of 2 patents to his name, his work has implications for various biological and medical applications.

Latest Patents

Collier's latest patents focus on methods for detecting RNA molecules using reverse transcriptase lacking RNAse H function. The disclosed methods utilize unique reverse transcription primers for specific RNA molecules, allowing for the detection of RNA/DNA hybrids with high specificity. This innovation enhances the ability to identify RNA from various organisms, including viruses, bacteria, fungi, plants, and animals. The methods can also be employed to detect reverse transcriptase activity and identify inhibitors, as well as for sequencing target RNA molecules.

Career Highlights

Collier is associated with Digene Corporation, where he has contributed to advancements in molecular diagnostics. His work has been pivotal in developing techniques that improve the accuracy and efficiency of RNA detection.

Collaborations

Some of his notable coworkers include Abel De La Rosa and James G Lazar, who have collaborated with him on various projects within the field.

Conclusion

Clayton D Collier's innovative approaches to RNA detection have the potential to significantly impact medical diagnostics and research. His contributions continue to advance the understanding and application of molecular biology techniques.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…